Ricke Loesnihari
Departemen Patologi Klinik Fakultas Kedokteran Universitas Sumatera Utara, Rumah Sakit Umum Pusat Haji Adam Malik Medan

Published : 15 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Journal of Telenursing (JOTING)

Kolesterol Total dan Kolesterol LDL terhadap hsCRP pada Pasien COVID-19 Berat Irawaty, Noni; Syafril, Santi; Loesnihari, Ricke
Journal of Telenursing (JOTING) Vol 5 No 2 (2023): Journal of Telenursing (JOTING)
Publisher : Institut Penelitian Matematika, Komputer, Keperawatan, Pendidikan dan Ekonomi (IPM2KPE)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31539/joting.v5i2.7251

Abstract

This study aims to examine the relationship between total LDL cholesterol and hsCRP in severe COVID-19 patients at the H. Adam Malik Hospital, Medan. The research method used was a cross-sectional retrospective study. The research results showed a negative correlation between Total Cholesterol and LDL Cholesterol and hsCRP in severe COVID-19 patients. In conclusion, a decrease in Total Cholesterol and LDL Cholesterol levels was found in severe COVID-19 patients. Increased hsCRP levels were found in severe COVID-19 patients. The demographic characteristics of the research subjects were dominated by male patients. The most common comorbidity found is Diabetes Mellitus Type 2, followed by hypertension. Keywords: Severe COVID-19, hsCRP, LDL Cholesterol, Total Cholesterol
Perbedaan Kadar Pentraxin 3 pada Penderita Hepatitis B Kronis dengan Cirrosis dan Tanpa Cirrosis Sasmita, Afrianda Wira; Sungkar, Taufik; Loesnihari, Ricke
Journal of Telenursing (JOTING) Vol 5 No 2 (2023): Journal of Telenursing (JOTING)
Publisher : Institut Penelitian Matematika, Komputer, Keperawatan, Pendidikan dan Ekonomi (IPM2KPE)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31539/joting.v5i2.7252

Abstract

This study aims to see differences in pentraxin 3 levels in chronic hepatitis B sufferers with cirrosis and without cirrosis. The method uses cross sectional consecutive sampling. The results of this study found a significant difference between the average value of Pentraxin 3 in chronic Hepatitis B patients with liver cirrhosis group compared to the group without liver cirrhosis (p<0.001). There was a significant difference between the Pentraxin 3 levels in the group of Chronic Hepatitis B sufferers with liver cirrhosis compared to the group of Chronic Hepatitis B sufferers without liver cirrhosis (p<0.001) where the Pentraxin 3 levels in the Chronic Hepatitis B group with liver cirrhosis were higher compared to the group without liver cirrhosis. In conclusion, Pentraxin 3 levels can be used as an alternative marker to assess the development of liver cirrhosis in Chronic Hepatitis B patients. Keywords: Chronic Hepatitis B, Liver cirrhosis, Pentraxin 3